McKesson Corporation

McKesson Corporation

MCKNYSEHealthcare
$1,004.84
up +6.2 (+0.62%)

1-Year Price

+31.34% past year
McKesson Corporation (MCK) 1-year price chart: up 31.34% from $765.08 on Oct 2025 to $1,004.84 on Oct 2026. Closing range $725.17 to $1,004.84.

EquityGlimpse Score

Overall
6.2/10
No Moat

No clear sustainable competitive advantage detected.

Growth
8

Valuation, profitability, financial health, dividend and sentiment scores for McKesson Corporation (MCK) are available to EquityGlimpse members.

Market Cap
117.15B
P/E Ratio
22.45
EPS
$38.53
52W High
$1,014.99
52W Low
$723.68
Volume
620.72K
Beta
0.3
Dividend Yield
0.36%
Fair value estimate: sign up to see
Is MCK over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
0.27
Price to Book
-49.24
EV/EBITDA
15.55
Free CF per Share
$43.77
Op. CF per Share
$49.80
Debt to Equity
-3.97
Gross Margin
3.61%
Net Margin
1.18%

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

CEO
Brian S. Tyler
Industry
Medical - Distribution
Employees
42,300
IPO Date
1994-11-10
Country
US
Unlock Full Analysis

Get the complete picture on McKesson Corporation

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for MCK and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling

Starting at $8.25/month. 7-day free trial. Cancel anytime.